Skip to main content

Table 5 Incidence of adverse events reported

From: Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

 

DPT (N = 206) n (%)

AL (N = 197) n (%)

Vomiting*

21 (10.2)

6(3)

Abdominal pain

5 (2.4)

3 (1.5)

Pruritus

6 (3)

2 (1)

Asthenia

2 (1)

5 (2.5)

Nausea

4 (2)

3 (1.5)

Dizziness

1 (0.5)

4 (2)

Epigastric pain

3 (1.5)

0 (0)

Diarrhoea

2 (1)

0 (0)

Skin rash

2(1)

0 (0)

Hypoglycaemia

0 (0)

2(1)

Insomnia

0 (0)

2 (1)

Facial oedema

0 (0)

2 (1)

Drowsiness

2 (1)

0 (0)

Aphthous ulcers

0 (0)

1 (0.5)

Skin fold lesions

0 (0)

1 (0.5)

Rash

1 (0.5)

0 (0)

Productive cough

1 (0.5)

0 (0)

Total

50

31

  1. * p = 0.038, Pearson's Chi-2 test